SpringerLink
Log in

Anaplastic Thyroid Carcinoma, Thyroid Lymphoma, and Metastases

  • Chapter
  • First Online:
Endocrine Surgery Comprehensive Board Exam Guide

  • 924 Accesses

Abstract

Less common tumors of the thyroid gland, while rare, contribute significantly to overall morbidity and mortality related to thyroid cancer. Anaplastic thyroid carcinoma, thyroid lymphoma, and metastases to the thyroid can be reviewed together as atypical presentations with important clinical features. Local invasion and airway management are among the critical factors to consider with these diseases. Swift diagnostic studies and pathologic confirmation will help in expediting treatment in these individuals. Surgical management is critical in some presentations. Novel treatments, reviewed here, are on the horizon for anaplastic thyroid carcinoma, with promise for improved survival. The critical issues of airway management in anaplastic thyroid carcinoma have been discussed in view of quality of life in these patients with quite limited life spans.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. O’Neill JP, Shaha AR. Anaplastic thyroid cancer. Oral Oncol. 2013;49:702–6.

    Article  PubMed  Google Scholar 

  2. Molinaro E, Romei C, Biagini A, et al. Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies. Nat Rev Endocrinol. 2017;13:644–60.

    Article  CAS  PubMed  Google Scholar 

  3. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States. JAMA. 2006;295:2164–7.

    Article  CAS  PubMed  Google Scholar 

  4. Kebebew E, Greenspan FS, Clark OH, et al. Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors. Cancer. 2005;103:1330–5.

    Article  PubMed  Google Scholar 

  5. Hundahl SA, Cady B, Cunningham MP, et al. Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the united states during. U.S. and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation study. Cancer. 2000;89:202–17.

    Article  CAS  PubMed  Google Scholar 

  6. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Database report on 53,856 cases of thyroid carcinoma treated in the US. Cancer. 1998;83:2638–48.

    Article  CAS  PubMed  Google Scholar 

  7. Besic N, Auersperg M, Us-Krasovec M, et al. Effect of primary treatment on survival in anaplastic thyroid carcinoma. Eur J Surg Oncol. 2001;27:260–4.

    Article  CAS  PubMed  Google Scholar 

  8. Wang SA, Rahemtullah A, Faquin WC, et al. Hodgkin’s lymphoma of the thyroid: a clinicopathologic study of five cases and review of the literature. Mod Pathol. 2005;18:1577.

    Article  PubMed  Google Scholar 

  9. Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer. 1972;29:252.

    Article  CAS  PubMed  Google Scholar 

  10. Gupta N, Nijhawan R, Srinivasan R, Rajwanshi A, Dutta P, Bhansaliy A, et al. Fine needle aspiration cytology of primary thyroid lymphoma: a report of ten cases. Cytojournal. 2005;2:21.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Skarsgard ED, Connors JM, Robins RE. A current analysis of primary lymphoma of the thyroid. Arch Surg. 1991;126:1199.

    Article  CAS  PubMed  Google Scholar 

  12. Junor EJ, Paul J, Reed NS. Primary non-Hodgkin’s lymphoma of the thyroid. Eur J Surg Oncol. 1992;18:313.

    CAS  PubMed  Google Scholar 

  13. Logue JP, Hale RJ, Stewart AL, et al. Primary malignant lymphoma of the thyroid: a clinicopathological analysis. Int J Radiat Oncol Biol Phys. 1992;22:929.

    Article  CAS  PubMed  Google Scholar 

  14. Wolf BC, Sheahan K, DeCoste D, et al. Immunohistochemical analysis of small cell tumors of the thyroid gland: an Eastern Cooperative Oncology Group study. Hum Pathol. 1992;23:1252.

    Article  CAS  PubMed  Google Scholar 

  15. Pedersen RK, Pedersen NT. Primary non-Hodgkin’s lymphoma of the thyroid gland: a population based study. Histopathology. 1996;28:25.

    Article  CAS  PubMed  Google Scholar 

  16. Holm LE, Blomgren H, Löwhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med. 1985;312:601.

    Article  CAS  PubMed  Google Scholar 

  17. Hyjek E, Isaacson PG. Primary B cell lymphoma of the thyroid and its relationship to Hashimoto’s thyroiditis. Hum Pathol. 1988;19:1315.

    Article  CAS  PubMed  Google Scholar 

  18. Chung AY, Tran TB, Brumund KT, Weisman RA, Bouvet M. Metastases to the thyroid: a review of the literature from the last decade. Thyroid. 2012;22(3):258–68.

    Article  PubMed  Google Scholar 

  19. Calzolari F, Sartori PV, Talarico C, Parmeggiani D, Beretta E, Pezzullo L, Bovo G, Sperlongano P, Monacelli M, Lucchini R, Misso C, Gurrado A, D’Ajello M, Uggeri F, Puxeddu E, Nasi P, Testini M, Rosato L, Barbarisio A, Avenia N. Surgical treatment of intrathyroid metastases: preliminary results of a multicentric study. Anticancer Res. 2008;28:2885–8.

    PubMed  Google Scholar 

  20. Papi G, Fadda G, Corsello SM, Corrado S, Rossi ED, Radighieri E, Miraglia A, Carani C, Pontecorvi A. Metastases to the thyroid gland: prevalence, clinicopathological aspects and prognosis: a 10-year experience. Clin Endocrinol. 2007;66:565–71.

    Google Scholar 

  21. Wood K, Vini L, Harmer C. Metastases to the thyroid gland: the Royal Marsden experience. Eur J Surg Oncol. 2004;30:583–8.

    Article  CAS  PubMed  Google Scholar 

  22. Kumamoto K, Utsumi Y, Sugano K, Hoshino M, Suzuki S, Takenoshita S. Colon carcinoma metastasis to the thyroid gland: report of a case with a review of the literature. Tumor. 2006;92:252–6.

    Article  Google Scholar 

  23. Cichon S, Anielski R, Konturek A, Barczynski M, Cichon W. Metastases to the thyroid gland: seventeen cases operated on in a single clinical center. Langenbeck’s Arch Surg. 2006;391:581–7.

    Article  Google Scholar 

  24. Mirallie E, Rigaud J, Mathonnet M, Gibelin H, Regenet N, Hamy A, Bretagnol F, de Calan L, Le Neel JC, Kraimps JL. Management and prognosis of metastases to the thyroid gland. J Am Coll Surg. 2005;200:203–7.

    Article  PubMed  Google Scholar 

  25. Peteiro A, Duarte AM, Honavar M. Breast carcinoma metastatic to follicular adenoma of the thyroid gland. Histopathology. 2005;46:587–8.

    Article  CAS  PubMed  Google Scholar 

  26. McIver B, Hay ID, Giuffrida DF, et al. Anaplastic thyroid carcinoma: a 50-year experience at a single institution. Surgery. 2001;130:1028–34.

    Article  CAS  PubMed  Google Scholar 

  27. Aldinger KA, Samaan NA, Ibanez M, Hill CS. Anaplastic carcinoma of the thyroid: a review of 84 cases of spindle and giant cell carcinoma of the thyroid. Cancer. 1978;41:2267–75.

    Article  CAS  PubMed  Google Scholar 

  28. Tupchong L, Hughes F, Harmer CL. Primary lymphoma of the thyroid: clinical features, prognostic factors, and results of treatment. Int J Radiat Oncol Biol Phys. 1986;12:1813.

    Article  CAS  PubMed  Google Scholar 

  29. Faulkner A, Maguire P. Teaching ward nurses to monitor cancer patients. Clin Oncol. 1984;10:383.

    CAS  PubMed  Google Scholar 

  30. Herrmann R, Panahon AM, Barcos MP, et al. Gastrointestinal involvement in non-Hodgkin’s lymphoma. Cancer. 1980;46:215.

    Article  CAS  PubMed  Google Scholar 

  31. Anscombe AM, Wright DH. Primary malignant lymphoma of the thyroid--a tumour of mucosa-associated lymphoid tissue: review of seventy-six cases. Histopathology. 1985;9:81.

    Article  CAS  PubMed  Google Scholar 

  32. Walsh S, Lowery AJ, Evoy D, et al. Thyroid lymphoma: recent advances in diagnosis and optimal management strategies. Oncologist. 2013;18:994.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Mazzaferri EL, Oertel YC. Primary malignant thyroid lymphoma and related lymphoproliferative disorders. In: Mazzaferri EL, Samaan NA, editors. Endocrine tumors. Boston: Blackwell Scientific; 1993. p. 348.

    Google Scholar 

  34. Alagol F, Tanakol R, Boztepe H, Kapran Y, Terzioglu T, Dizdaroglu F. Anaplastic thyroid cancer with transient thyrotoxicosis: case report and literature review. Thyroid. 1999;9(10):1029–32.

    Article  CAS  PubMed  Google Scholar 

  35. Heymann RS, Brent GA, Hershman JM. Anaplastic thyroid carcinoma with thyrotoxicosis and hypoparathyroidism. Endocr Pract. 2005;11:281–4.

    Article  PubMed  Google Scholar 

  36. Zeki K, Eto S, Fujihira T, et al. Primary malignant lymphoma of the thyroid in a patient with long-standing Graves’ disease. Endocrinol Jpn. 1985;32:435.

    Article  CAS  PubMed  Google Scholar 

  37. Foppiani L, Secondo V, Arlandini A, Quilici P, Cabria M, Del Monte P. Thyroid lymphoma: a rare tumor requiring combined management. Hormones (Athens). 2009;8:214–8.

    Article  Google Scholar 

  38. Thieblemont C, Bastion Y, Berger F, Rieux C, Salles G, Dumontet C, et al. Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patients. J Clin Oncol. 1997;15:1624–30.

    Article  CAS  PubMed  Google Scholar 

  39. Cheung AY, Donner L, Capen C. Metastatic adenocarcinoma of the uterine cervix to the thyroid gland. Clin Oncol (R Coll Radiol). 2000;12:60–1.

    Article  CAS  Google Scholar 

  40. Poon D, Toh HC, Sim CS. Two case reports of metastases from colon carcinoma to the thyroid. Ann Acad Med Singap. 2004;33:100–2.

    CAS  PubMed  Google Scholar 

  41. Filosso PL, Arslanian A, Palestini N, Farnetti A, Papotti M, Bongiovanni M, Giobbe R, Ruffini E. Thyroid metastasis after resection of atypical bronchial carcinoid. J Thorac Cardiovasc Surg. 2004;127:1840–3.

    Article  PubMed  Google Scholar 

  42. Kihara M, Miyauchi A, Yamauchi A, Yokomise H. Prognostic factors of anaplastic thyroid carcinoma. Surg Today. 2004;34:394–8.

    Article  PubMed  Google Scholar 

  43. Brandwein-Gensler M, Urken M, Wang B. Collision tumor of the thyroid: a case report of metastatic liposarcoma plus papillary thyroid carcinoma. Head Neck. 2004;26:637–41.

    Article  PubMed  Google Scholar 

  44. Smallridge RC, Ain KB, Asa SL, et al. American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid. 2012;22:1104–39.

    Article  PubMed  Google Scholar 

  45. Matsuzuka F, Miyauchi A, Katayama S, et al. Clinical aspects of primary thyroid lymphoma: diagnosis and treatment based on our experience of 119 cases. Thyroid. 1993;3:93.

    Article  CAS  PubMed  Google Scholar 

  46. National Comprehensive Cancer Network. Thyroid Cancer (Version 1.2020). https://www.nccn.org/professionals/physician_gls/pdf/thyroid.pdf. Accessed July 15, 2020.

  47. Carcangiu ML, Steeper T, Zampi G, Rosai J. Anaplastic thyroid carcinoma. A study of 70 cases. Am J Clin Pathol. 1985;83:135–58.

    Article  CAS  PubMed  Google Scholar 

  48. Venkatesh YS, Ordonez NG, Schultz PN, Hickey RC, Goepfert H, Samaan NA. Anaplastic carcinoma of the thyroid. A clinicopathologic study of 121 cases. Cancer. 1990;66:321–30.

    Article  CAS  PubMed  Google Scholar 

  49. Bronner MP, LiVolsi VA. Spindle cell squamous carcinoma of the thyroid: an unusual anaplastic tumor associated with tall cell papillary cancer. Mod Pathol. 1991;4:637–43.

    CAS  PubMed  Google Scholar 

  50. Ordonez NG, El-Naggar AK, Hickey RC, Samaan NA. Anaplastic thyroid carcinoma. Immunocytochemical study of 32 cases. Am J Clin Pathol. 1991;96:15–24.

    Article  CAS  PubMed  Google Scholar 

  51. Gaffey MJ, Lack EE, Christ ML, Weiss LM. Anaplastic thyroid carcinoma with osteoclast-like giant cells. A clinicopathologic, immunohistochemical, and ultrastructural study. Am J Surg Pathol. 1991;15:160–8.

    Article  CAS  PubMed  Google Scholar 

  52. Seethala RR, Nikiforov YE. Anaplastic (undifferentiated) carcinoma. In: Nikiforov YE, Biddinger PW, Thompson LDR, editors. Diagnostic pathology and molecular genetics of the thyroid: a comprehensive guide for practicing thyroid pathology. Philadelphia: Lippincott Williams & Wilkins; 2009. p. 228–48.

    Google Scholar 

  53. Verma D, Puri V, Agarwal S, Bhaskar A. Primary thyroid lymphoma: a rare disease. J Cytol. 2014;31(4):218–20.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Swart GJ, Wright C, Brundyn K, et al. Fine needle aspiration biopsy and flow cytometry in the diagnosis of lymphoma. Transfus Apher Sci. 2007;37:71–9.

    Article  PubMed  Google Scholar 

  55. Swart GJ, Wright CA. The utilization of fine needle aspiration biopsy (FNAB) and flow cytometry (FC) in the diagnosis and classification of non-Hodgkin B-cell and T-cell lymphomas. Transfus Apher Sci. 2010;42:199–207.

    Article  PubMed  Google Scholar 

  56. Ravinsky E, Morales C. Diagnosis of lymphoma by image-guided needle biopsies: fine needle aspiration biopsy, core biopsy or both? Acta Cytol. 2005;49(1):51–7.

    Article  PubMed  Google Scholar 

  57. Miyakoshi A, Dalley R, Anzai Y. Magnetic resonance imaging of thyroid cancer. Top Magn Reson Imaging. 2007;18:293–302.

    Article  PubMed  Google Scholar 

  58. Chiacchio S, Lorenzoni A, Boni G, et al. Anaplastic thyroid cancer: prevalence, diagnosis and treatment. Minerva Endocrinol. 2008;33:341–57.

    CAS  PubMed  Google Scholar 

  59. Perrier ND, Brierley JD, Tuttle RM. Differentiated and anaplastic thyroid carcinoma: major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J Clin. 2018;68:55–63.

    Article  PubMed  Google Scholar 

  60. Tuttle RM, Haugen B, Perrier ND. Updated American Joint Committee on cancer/tumor-node-metastasis staging system for differentiated and anaplastic thyroid cancer (eighth edition): what changed and why? Thyroid. 2017;27:751–6.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, Lister TA. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32(27):3059–68.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Sugino K, Ito K, Mimura T, et al. The important role of operations in the management of anaplastic thyroid carcinoma. Surgery. 2002;131:245–8.

    Article  PubMed  Google Scholar 

  63. Smallridge RC, Marlow LA, Copland JA. Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies. Endocr Relat Cancer. 2009;16(1):17–44.

    Article  CAS  PubMed  Google Scholar 

  64. Smallridge RC, Copland JA. Anaplastic thyroid carcinoma: pathogenesis and emerging therapies. Clin Oncol (R Coll Radiol). 2010;22(6):486–97.

    Article  CAS  Google Scholar 

  65. Soares P, Lima J, Preto A, Castro P, Vinagre J, Celestino R, Couto JP, Prazeres H, Eloy C, Máximo V, Sobrinho-Simões M. Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomas. Curr Genomics. 2011;12(8):609–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Subbiah V, Kreitman RJ, Wainberg ZA, et al. Dabrafenib and Trametinib treatment in patients with locally advanced or metastatic BRAF V600-mutant anaplastic thyroid cancer. J Clin Oncol. 2018;36(1):7–13.

    Article  CAS  PubMed  Google Scholar 

  67. Landa I, Ibrahimpasic T, Boucai L, Sinha R, Knauf JA, Shah RH, Dogan S, Ricarte-Filho JC, Krishnamoorthy GP, Xu B, Schultz N, Berger MF, Sander C, Taylor BS, Ghossein R, Ganly I, Fagin JA. Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. J Clin Invest. 2016;126:1052–66.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Pozdeyev N, Gay LM, Sokol ES, Hartmaier R, Deaver KE, Davis S, French JD, Borre PV, LaBarbera DV, Tan AC, Schweppe RE, Fishbein L, Ross JS, Haugen BR, Bowles DW. Genetic analysis of 779 advanced differentiated and anaplastic thyroid cancers. Clin Cancer Res. 2018;24:3059–68.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Chen H, Luthra R, Routbort MJ, Patel KP, Cabanillas ME, Broaddus RR, Williams MD. Molecular profile of advanced thyroid carcinomas by next-generation sequencing: characterizing tumors beyond diagnosis for targeted therapy. Mol Cancer Ther. 2018;17:1575–84.

    Article  CAS  PubMed  Google Scholar 

  70. Begum S, Rosenbaum E, Henrique R, Cohen Y, Sidransky D, Westra WH. BRAF mutations in anaplastic thyroid carcinoma: implications for tumor origin, diagnosis and treatment. Mod Pathol. 2004;17:1359–63.

    Article  CAS  PubMed  Google Scholar 

  71. Drilon A, Laetsch TW, Kummar S, et al. Efficacy of Larotrectinib in TRK fusion-positive cancers in adults and children. N Engl J Med. 2018;378(8):731–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Doebele RC, Drilon A, Paz-Ares L, et al. Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials. Lancet Oncol. 2020;21(2):271–82.

    Article  CAS  PubMed  Google Scholar 

  73. Dias-Santagata D, Lennerz JK, Sadow PM, et al. Response to RET-specific therapy in RETFusion-positive anaplastic thyroid carcinoma [published online ahead of print, 2020 May 19]. Thyroid. 2020;30(9):1384–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Tahara M, et al. Lenvatinib for anaplastic thyroid cancer. Front Oncol. 2017;7:25.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Marabelle A, et al. Association of tumor mutational burden with outcomes in patients with select advanced solid tumors treated with pembrolizumab in KEYNOTE-158. Presented at the Annual Meeting of ESMO in Barcelona, Spain, September 30, 2019.

    Google Scholar 

  76. Ha CS, Shadle KM, Medeiros LJ, et al. Localized non-Hodgkin lymphoma involving the thyroid gland. Cancer. 2001;91:629.

    Article  CAS  PubMed  Google Scholar 

  77. El Fakih RO, Delgado FA, Harstine LR. Marked thyroid enlargement secondary to renal cell carcinoma metastasis with acute respiratory failure. Thyroid. 2009;19:917–8.

    Article  PubMed  Google Scholar 

  78. Yau T, Lo CY, Epstein RJ, Lam AK, Wan KY, Lang BH. Treatment outcomes in anaplastic thyroid carcinoma: survival improvement in young patients with localized disease treated by combination of surgery and radiotherapy. Ann Surg Oncol. 2008;15(9):2500–5.

    Article  PubMed  Google Scholar 

  79. Wang JR, Zafereo ME, Dadu R, et al. Complete surgical resection following neoadjuvant dabrafenib plus trametinib in BRAFV600E-mutated anaplastic thyroid carcinoma. Thyroid. 2019;29:1036–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Cabanillas ME, Ferrarotto R, Garden AS, et al. Neoadjuvant BRAF- and immune-directed therapy for anaplastic thyroid carcinoma. Thyroid. 2018;28:945–51.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Czech JM, Lichtor TR, Carney JA, van Heerden JA. Neoplasms metastatic to the thyroid gland. Surg Gynecol Obstet. 1982;155:503–5.

    CAS  PubMed  Google Scholar 

  82. Ericsson M, Biorklund A, Cederquist E, Ingemansson S, Aker-man M. Surgical treatment of metastatic disease in the thyroid gland. J Surg Oncol. 1981;17:15–23.

    Article  CAS  PubMed  Google Scholar 

  83. Ishikawa M, Hirano S, Tsuji T, Ito J. Management of metastasis to the thyroid gland. Auris Nasus Larynx. 2011;38:426–30.

    Article  PubMed  Google Scholar 

  84. Nixon IJ, Whitcher M, Glick J, et al. Surgical management of metastases to the thyroid gland. Ann Surg Oncol. 2011;18:800–4.

    Article  PubMed  Google Scholar 

  85. Iesalnieks I, Winter H, Bareck E, et al. Thyroid metastases of renal cell carcinoma: clinical course in 45 patients undergoing surgery. Assessment of factors affecting patients’ survival. Thyroid. 2008;18:615–24.

    Article  PubMed  Google Scholar 

  86. Russell JO, Yan K, Burkey B, Scharpf J. Nonthyroid metastasis to the thyroid gland: case series and review with observations by primary pathology. Otolaryngol Head Neck Surg. 2016;155(6):961–8.

    Article  PubMed  Google Scholar 

  87. Patel KN, Shaha AR. Poorly differentiated thyroid cancer. Curr Opin Otolaryngol Head Neck Surg. 2014;22:121–6.

    Article  CAS  PubMed  Google Scholar 

  88. Neff R, Farrar W, Kloos R, Burman K. Anaplastic thyroid cancer. Endocrinol Metab Clin N Am. 2008;37:525–38.

    Article  Google Scholar 

  89. Besic N, Hocevar M, Zgajnar J, Pogacnik A, Grazio-Frkovic S, Auersperg M. Prognostic factors in anaplastic carcinoma of the thyroid-a multivariate survival analysis of 188 patients. Langenbeck’s Arch Surg. 2005;390(3):203–8.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Otorhinolaryngology, University of Maryland School of Medicine, Baltimore, MD, USA

    Kelly F. Moyer

  2. Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    Richard J. Wong

  3. Memorial Sloan Kettering Cancer Center, New York, NY, USA

    Ashok R. Shaha

Authors
  1. Kelly F. Moyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Richard J. Wong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ashok R. Shaha
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ashok R. Shaha .

Editor information

Editors and Affiliations

  1. Department of Surgery, Jersey Shore University Medical Center, Neptune, NJ, USA

    Alexander L. Shifrin

  2. Division of Endocrine and Metabolic Surgery, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy

    Marco Raffaelli

  3. The Claire and John Bertucci Endowed Chair in Thyroid Surgical Oncology, Harvard Medical School, Boston, MA, USA

    Gregory W. Randolph

  4. Department of Surgery, Linkö** University, Linkö**, Sweden

    Oliver Gimm

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Moyer, K.F., Wong, R.J., Shaha, A.R. (2021). Anaplastic Thyroid Carcinoma, Thyroid Lymphoma, and Metastases. In: Shifrin, A.L., Raffaelli, M., Randolph, G.W., Gimm, O. (eds) Endocrine Surgery Comprehensive Board Exam Guide. Springer, Cham. https://doi.org/10.1007/978-3-030-84737-1_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-84737-1_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-84736-4

  • Online ISBN: 978-3-030-84737-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation